Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Conditions:   Glioma;   Glioblastoma Multiforme Intervention:   Drug: APG-157 Sponsor:   Aveta Biomics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials